Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials

Journal of Biopharmaceutical Statistics

Volumn 17, Issue 2, 2007, Pages 247-257

  Tsong, Yi ^a,b   Zhang, Joanne ^a  

^a CDER   (United States)

^b Office of Biostatistics   (United States)

Author keywords

Assay sensitivity; Noninferiority test; Simultaneous test; Superiority test

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; HYPOTHESIS; PRIORITY JOURNAL; SIMULATION;

CONFIDENCE INTERVALS; CONTROLLED CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN;

EID: 33947216182     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400601177434     Document Type: Article

References (16)

1. Hasselblad, V., Kong, D. F. (2001). Statistical methods for comparison to placebo in activecontrol trials. Drug Inf. J. 35:435-449.
2. Hauschke, D., Kieser, M., Diletti, E., Burke, M. (1999). Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Stat. Med. 18:93-105.
3. Holmgren, E. B. (1999). Establishing equivalence by showing that a prespecified percentage of the effect of the active control over placebo is maintained. J. Biopharm. Stat. 9:651-659.
4. Hung, H.-M. J., Wang, S.-J. (2004). Multiple testing of noninferiority hypothesis in active controlled trials. J. Biopharm. Stat. 14:327-335.
5. Hung, H.-M. J., Wang, S.-J., Tsong, Y., Lawrence, J., O'Neill, R. T. (2003). Some fundamental issues for noninferiority testing in active controlled trials. Stat. Med. 22:213-225.
6. Koti, K. M. (2005). Use of the Fieller-Hienley distribution of the ratio of random variables in testing for noninferiority and equivalence. 2005 ASA Proceedings, CD version, pp. 599-606.
7. Morikawa, T., Yoshida, M. (1995). A useful testing strategy in phase III trials: Combined test of superiority and test of equivalence. J. Biopharm. Stat. 5:297-306.
8. Pigeot, I., Schafer, J., Röhmel, J., Hauschke, D. (2003). Assessing noninferiority of a new treatment in a three-arm clinical trial including a placebo. Stat. Med. 22:883-899.
9. Röhmel, J., Hauschke, D. (2006). Letter to editor: Testing superiority and noninferiority hypotheses for active controlled clinical trials. Biomet. J. 48:74-175.
10. Rothman, M., Li, N., Chen, G., Chi, G., Tsou, H. H. (2003). Design and analysis of noninferiority mortality trials in oncology. Stat. Med. 22:239-264.
11. Satterthwaite, F. E. (1946). An approximate distribution of estimates of variance components. Biomet. Bull. 2:110-114.
12. Tsong, Y., Zhang, J. (2005). Testing superiority and noninferiority hypotheses in active controlled clinical trials. Biomet. J. 47:62-74.
13. Tsong, Y., Zhang, J. (2006). Authors' Reply. Biomet. J. 48:176.
14. Tsong, Y., Wang, S.-J., Hung, H.-M. J. (2003). Statistical issues in objectives, designs, and analysis of noninferiority test active controlled clinical trials. J. Biopharm. Stat. 13:29-41.
15. Wang, S.-J., Hung, H.-M. J., Tsong, Y. (2002). Utility and pitfall of some statistical methods in active controlled clinical trials. Contr. Clinic. Trials 23:15-28.
16. Wang, Y. C., Chen, G., Chi, G. Y. H. (2006). A ratio test in active control noninferiority trials with a time-to-event endpoint. J. Biopharm. Stat. 16:151-164.